SCHEMBL2373434

SCHEMBL2373434

CN(C)C(=O)c1ccc(CNC(=O)c2csc(Nc3ccncn3)n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TRPV4 Q9HBA0 1/20 0.44
EPHX2 P34913 1/20 0.43
NR1H4 Q96RI1 1/20 0.43
MPL P40238 12/20 0.42
CYP1A2 P05177 2/20 0.40
CYP3A4 P08684 2/20 0.40
USP2 O75604 1/20 0.40
ALDH1A1 P00352 1/20 0.40
CYP2D6 P10635 1/20 0.40
MAPK1 P28482 1/20 0.40
POLB P06746 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
CACNA1G O43497 1/20 0.39
CACNA1H O95180 1/20 0.39
CACNA1I Q9P0X4 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2374577 0.88 MPL (0.46) TRPV4MPLMAPK1SMN1; SMN2
SCHEMBL2373945 0.87 NAMPT (0.46) TRPV4MPLCYP1A2CYP3A4CYP2D6
SCHEMBL24139180 0.87 SMN1; SMN2 (0.53) TRPV4MPLCYP1A2CYP3A4MAPK1
SCHEMBL669856 0.85 MMP13 (0.48) MPLALDH1A1MAPK1SMN1; SMN2
SCHEMBL29072859 0.85 MMP13 (0.48) MPLALDH1A1MAPK1SMN1; SMN2
SCHEMBL2373405 0.84 CYP1A2 (0.58) CYP1A2CYP3A4ALDH1A1CYP2D6MAPK1
SCHEMBL2374491 0.84 NAMPT (0.48) TRPV4MPLSMN1; SMN2
SCHEMBL12254348 0.83 CYP1A2 (0.41) TRPV4EPHX2NR1H4MPLCYP1A2
SCHEMBL24180538 0.80 GAA (0.45) MPLMAPK1
SCHEMBL2373894 0.80 HTT (0.55) USP2ALDH1A1POLBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12410397-B2 Methods of enhancing cell survival of stem cells THE SCRIPPS RESEARCH INSTITUTE (US) 2025-09-09 US disclosed
EP-4585589-A2 STEM CELL CULTURES The Scripps Research Institute (US) 2025-07-16 EP disclosed
EP-4296270-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2025-06-18 EP disclosed
EP-4296270-A2 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2023-12-27 EP disclosed
EP-3936508-B1 A COMPOSITION COMPRISING STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2023-12-06 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
EP-3936508-A1 A COMPOSITION COMPRISING STEM CELL CULTURES The Scripps Research Institute (US) 2022-01-12 EP disclosed
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS THE SCRIPPS RESEARCH INSTITUTE 2021-12-30 US disclosed
EP-3623374-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2021-09-08 EP disclosed
EP-3623374-B1 STEM CELL CULTURES SCRIPPS RESEARCH INST (US) 2021-09-08 EP disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-20110294761-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-12-01 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-8044201-B2 Stem cell cultures THE SCRIPPS RESEARCH INSTITUTE (US) 2011-10-25 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
US-20110224233-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2011-09-15 US disclosed
WO-2010065721-A1 STEM CELL CULTURES THE SCRIPPS RESEARCH INSTITUTE (US) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110294761-A1 STEM CELL CULTURES NES, CD44, MCL1 TRPV4 4274/4885EPHX2 2480/4885NR1H4 2920/4885
US-12410397-B2 Methods of enhancing cell survival of stem cells MCL1, BCL2, BCLAF1 TRPV4 4805/4885EPHX2 3345/4885NR1H4 3843/4885
US-20210403862-A1 METHODS OF ENHANCING CELL SURVIVAL OF STEM CELLS MCL1, BCL2, BCLAF1 TRPV4 4805/4885EPHX2 3345/4885NR1H4 3843/4885
US-20110224233-A1 STEM CELL CULTURES NES, CD44, MCL1 TRPV4 4274/4885EPHX2 2480/4885NR1H4 2920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.